Zohran Mamdani Has a Chance To Fight Price Gouging

Many Americans became aware of the problem of price gouging in 2016, when the cost of a two-pack of EpiPens, which in 2007 was about $100, went over $600. This astronomical increase did not reflect product innovation or new production costs; the EpiPen, a portable injector used to treat severe allergic reactions, is fairly cheap to manufacture. Rather, the sky-high price seemed to reflect the fact that the EpiPen is a necessary and often lifesaving piece of equipment — and that in the absence of meaningful alternatives, people will pay pretty much whatever they have to. Read Full Article »